Drug Shortage Report for ZAROXOLYN

Last updated on 2023-05-10 History
Report ID 191769
Drug Identification Number 00888400
Brand name ZAROXOLYN
Common or Proper name ZAROXOLYN
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) METOLAZONE
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C03BA
ATC description LOW-CEILING DIURETICS, EXCL THIAZIDES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2023-05-04
Estimated end date 2023-05-31
Actual end date 2023-05-09
Shortage status Resolved
Updated date 2023-05-10
Company comments Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2023-05-10 English Compare
v5 2023-05-09 French Compare
v4 2023-05-09 English Compare
v3 2023-05-05 French Compare
v2 2023-05-05 French Compare
v1 2023-05-05 English Compare

Showing 1 to 6 of 6